| scholarly article | Q13442814 |
| P50 | author | Daniel Saiz | Q42872432 |
| Alino Martinez-Marcos | Q71413413 | ||
| Isabel Úbeda Bañón | Q73650561 | ||
| Carlos de la Rosa-Prieto | Q80117373 | ||
| Alicia Flores-Cuadrado | Q85856501 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 13-21 | |
| P577 | publication date | 2015-11-23 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | Interneurons in the human olfactory system in Alzheimer's disease | |
| P478 | volume | 276 |
| Q47150284 | Differential Effects of Parkinson's Disease on Interneuron Subtypes within the Human Anterior Olfactory Nucleus. |
| Q97882884 | GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment |
| Q38799836 | Graveoline Analogs Exhibiting Selective Acetylcholinesterase Inhibitory Activity as Potential Lead Compounds for the Treatment of Alzheimer's Disease. |
| Q93111924 | Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization |
| Q52905119 | INTERNEURONOPATHIES AND THEIR ROLE IN EARLY LIFE EPILEPSIES AND NEURODEVELOPMENTAL DISORDERS. |
| Q37487771 | Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment |
| Q64111293 | Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model |
| Q36947147 | Neurogenesis, Neurodegeneration, Interneuron Vulnerability, and Amyloid-β in the Olfactory Bulb of APP/PS1 Mouse Model of Alzheimer's Disease. |
| Q53693180 | Olfactory Dysfunction as a Global Biomarker for Sniffing out Alzheimer's Disease: A Meta-Analysis. |
| Q64062929 | Somatostatin Serves a Modulatory Role in the Mouse Olfactory Bulb: Neuroanatomical and Behavioral Evidence |
| Q57486415 | Somatostatin and Neuropeptide Y in Cerebrospinal Fluid: Correlations With Amyloid Peptides Aβ and Tau Proteins in Elderly Patients With Mild Cognitive Impairment |
| Q91640038 | The Mechanism of Compound Anshen Essential Oil in the Treatment of Insomnia Was Examined by Network Pharmacology |
| Q50348623 | Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin |
Search more.